BIOFLOW-INDIA Safety and Clinical PerFormance of the Drug Eluting ORSIRO Stent in Single de Novo Coronary Artery Lesions
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 120 participants.
Also called NCT01426139
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 120 participants
- Sponsor
- Registry
-
NCT01426139
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- India
- Registry status
- Completed
Technical summary
Registry record NCT01426139. Non-randomized; no masking; primary purpose treatment. Start 2011-08 (registry gives no type); primary completion 2012-11 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- BIOFLOW-INDIA Safety and Clinical PerFormance of the Drug Eluting ORSIRO Stent in Single de Novo Coronary Artery Lesions
- Condition
- Coronary Artery Disease
- Intervention (Device)
- Percutaneous Coronary Intervention Biotronik Orsiro DES
- Lead sponsor
- Biotronik AG
Record details
- Record id
cardio:ct-nct01426139- Content hash
b51a55ca040d4b0675307208fed165b0736c0a6656b5bb2fe40aed5a62a9ecde